Selective Binding of Antiinfluenza Drugs and Their Analogues to 'Open' and 'Closed' Conformations of H5N1 Neuraminidase

被引:16
|
作者
Wang, Pei [3 ]
Zhang, John Z. H. [1 ,2 ,3 ]
机构
[1] E China Normal Univ, Inst Theoret & Computat Sci, Shanghai 200062, Peoples R China
[2] E China Normal Univ, State Key Lab Precis Spectroscopy, Dept Phys, Shanghai 200062, Peoples R China
[3] New York Univ, Dept Chem, New York, NY 10003 USA
来源
JOURNAL OF PHYSICAL CHEMISTRY B | 2010年 / 114卷 / 40期
关键词
MOLECULAR-DYNAMICS; FREE-ENERGIES; CONTINUUM SOLVENT; MM-PBSA; INHIBITORS; PREDICTION; EFFICIENT; DOCKING; DESIGN;
D O I
10.1021/jp1030224
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
It was suggested that the open conformation of the 150-loop of H5N1 I avian influenza neuraminidase is intrinsically lower in energy than the closed conformation and that oseltamivir (tamiflu) favors binding to the closed conformation through a relatively slow conformational change [Russell, R. J. Nature 2006, 443, 45-491. In the present work, a systematic computational study is performed to investigate the binding mechanism of five ligands to H5N1 neurarninidase (H5N1 NA) with the 150-loop in both open and closed conformations through molecular docking, molecular dynamics simulations, and MM/PBSA free energy calculation. Our result shows that the electrostatic interactions between polar groups on the 150-loop and the charged groups of the ligands play a key role on the binding selectivity. In particular, ligands having a small positively charged group favor binding to the closed conformation of H5N1 I NA, while those having a large positively charged group generally prefer binding to the open conformation. Our analysis suggests that it may be possible to design new inhibitors with large basic groups that are selective for the open conformation and thereby have stronger binding affinity to H5N1 I neuraminidase.
引用
收藏
页码:12958 / 12964
页数:7
相关论文
共 50 条
  • [31] Influenza A(H5N1)
    不详
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 (02) : 92 - 92
  • [32] H5N1 antibodies
    Hampton, Tracy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (01): : 32 - 32
  • [33] INTRODUCTION H5N1
    Alberts, Bruce
    SCIENCE, 2012, 336 (6088) : 1521 - 1521
  • [34] H5N1阴影
    易杳
    瞭望新闻周刊, 2004, (19) : 54 - 55
  • [35] Discover binding pathways using the sliding binding-box docking approach: application to binding pathways of oseltamivir to avian influenza H5N1 neuraminidase
    Diem-Trang T. Tran
    Ly T. Le
    Thanh N. Truong
    Journal of Computer-Aided Molecular Design, 2013, 27 : 689 - 695
  • [36] Discover binding pathways using the sliding binding-box docking approach: application to binding pathways of oseltamivir to avian influenza H5N1 neuraminidase
    Tran, Diem-Trang T.
    Le, Ly T.
    Truong, Thanh N.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2013, 27 (08) : 689 - 695
  • [37] An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses
    Shoji, Yoko
    Chichester, Jessica A.
    Palmer, Gene A.
    Farrance, Christine E.
    Stevens, Robert
    Stewart, Michelle
    Goldschmidt, Lauren
    Deyde, Varough
    Gubareva, Larisa
    Klimov, Alexander
    Mett, Vadim
    Yusibov, Vidadi
    HUMAN VACCINES, 2011, 7 : 199 - 204
  • [38] Analysis of decrease in sensitivity in influenza A (H5N1) avian and human strains to neuraminidase inhibitors
    Reina, J.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2008, 21 (01) : 32 - 36
  • [39] Docking study on chlorogenic acid as a potential H5N1 influenza A virus neuraminidase inhibitor
    Luo, Hua-Jun
    Wang, Jun-Zhi
    Chen, Jian-Feng
    Zou, Kun
    MEDICINAL CHEMISTRY RESEARCH, 2011, 20 (05) : 554 - 557
  • [40] Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus
    Mao Shu
    Zhihua Lin
    Yunru Zhang
    Yuqian Wu
    Hu Mei
    Yongjun Jiang
    Journal of Molecular Modeling, 2011, 17 : 587 - 592